Tazemetostat and Palbociclib With CPX-351for R/R AML
Tazemetostat and Palbociclib With CPX-351for R/R AML
Recruiting · NCT05627232 · Registry updated 2026-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tazemetostat and Palbociclib With CPX-351for R/R AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-03-12 | NCT05627232 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pennsylvania Department of Health | 6 |
| Thomas Jefferson University | 115 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia | United States | 271 |